Targeting the TGFβ signalling pathway in disease.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2012 AND VI 11 AND IP 10
Results: 29
1
2
Bacterial proteolytic complexes as therapeutic targets.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Targeting IL-17 and TH17 cells in chronic inflammation.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Michael Snyder. Interview by Asher Mullard.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
5
The determination and interpretation of the therapeutic index in drug development.
- Published in:
- 2012
- By:
- Publication type:
- journal article
6
Vaccines: Self-amplifying RNA in lipid nanoparticles: a next-generation vaccine?
- Published in:
- 2012
- By:
- Publication type:
- journal article
7
Targeting IL-17 and T<sub>H</sub>17 cells in chronic inflammation.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 763, doi. 10.1038/nrd3794
- By:
- Publication type:
- Article
8
Moving from an asthma pipe dream to a pipeline.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 737, doi. 10.1038/nrd3858
- By:
- Publication type:
- Article
9
Bacterial proteolytic complexes as therapeutic targets.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 777, doi. 10.1038/nrd3846
- By:
- Publication type:
- Article
10
Michael Snyder.
- Published in:
- 2012
- Publication type:
- Interview
11
Neurodegenerative disease: EPHA4 inhibition rescues neurodegeneration in ALS.
- Published in:
- 2012
- By:
- Publication type:
- journal article
12
Trial watch: Dual-acting combination meets heart failure end point.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 740, doi. 10.1038/nrd3855
- By:
- Publication type:
- Article
13
The determination and interpretation of the therapeutic index in drug development.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 751, doi. 10.1038/nrd3801
- By:
- Publication type:
- Article
14
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 731, doi. 10.1038/nrd3848
- Publication type:
- Article
15
Connecting the dots in translational research.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 811, doi. 10.1038/nrd3357-c2
- By:
- Publication type:
- Article
16
Inflammatory disorders: Separating good from bad.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 750, doi. 10.1038/nrd3852
- By:
- Publication type:
- Article
17
Anticancer drugs: Tumour delivery of RNA interference.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 750, doi. 10.1038/nrd3862
- By:
- Publication type:
- Article
18
Antiviral drugs: Protection against influenza B infection.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 750, doi. 10.1038/nrd3863
- By:
- Publication type:
- Article
19
Cancer: A new target in Burkitt's lymphoma.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 750, doi. 10.1038/nrd3860
- By:
- Publication type:
- Article
20
Targeting the TGF? signalling pathway in disease.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 790, doi. 10.1038/nrd3810
- By:
- Publication type:
- Article
21
Autism spectrum disorders.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 745, doi. 10.1038/nrd3771
- By:
- Publication type:
- Article
22
Market watch: Upcoming market catalysts in Q4 2012.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 740, doi. 10.1038/nrd3856
- By:
- Publication type:
- Article
23
Economists propose a US$30 billion boost to biomedical R&D.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 735, doi. 10.1038/nrd3857
- By:
- Publication type:
- Article
24
In search of preclinical robustness.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 733, doi. 10.1038/nrd3849
- By:
- Publication type:
- Article
25
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 742, doi. 10.1038/nrd3866
- By:
- Publication type:
- Article
26
Metabolic disorders: Safe cannabinoid receptor modulators in sight?
- Published in:
- 2012
- By:
- Publication type:
- journal article
27
Neurodegenerative diseases: Anti-epileptic drug shows benefit in AD mouse model.
- Published in:
- 2012
- By:
- Publication type:
- journal article
28
News in brief.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 739, doi. 10.1038/nrd3865
- Publication type:
- Article
29
Epigenetic targets: Towards a male contraceptive?
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 10, p. 750, doi. 10.1038/nrd3861
- By:
- Publication type:
- Article